| 1 | 1/1 | 返回列表 |
| 查看: 463 | 回復(fù): 0 | |||
deng71新蟲 (初入文壇)
|
[交流]
湖南科技大學(xué)化學(xué)化工學(xué)院接收調(diào)劑
|
|
湖南科技大學(xué)化學(xué)化工學(xué)院擬調(diào)劑10人,要求過國家A線,專業(yè)代碼0703或0817優(yōu)先,有意者請發(fā)簡歷或個人情況至郵箱:3313554847@qq.com,郵件主題:調(diào)劑申請+姓名+初試成績+本科專業(yè)。 萬義超,男,1988年生,博士,副教授,碩士生導(dǎo)師,現(xiàn)為湖南科技大學(xué)理論有機(jī)化學(xué)與功能分子教育部重點(diǎn)實(shí)驗(yàn)室專職科研人員。主要從事基于靶點(diǎn)結(jié)構(gòu)的藥物設(shè)計(jì)、合成及生物活性研究及化學(xué)生物學(xué)的研究。近年來主持國家自然科學(xué)基金青年項(xiàng)目1項(xiàng),湖南省自然科學(xué)基金1項(xiàng),湖南省教育廳項(xiàng)目1項(xiàng),湖南科技大學(xué)博士科研基金1項(xiàng),重點(diǎn)實(shí)驗(yàn)室開放課題1項(xiàng),參與國家自然科學(xué)基金3項(xiàng)。在J. Med. Chem.、Eur. J. Med. Chem.、Bioorg. Med. Chem.、Bioorg. Chem.、Curr. Med. Chem.、Future Med. Chem. 等國內(nèi)外知名期刊上發(fā)表論文22篇。 聯(lián)系方式:Email: 07wanyichao@hnust.edu.cn;07wanyichao@163.com。 教育背景 2011/09-2016/06,山東大學(xué),藥學(xué)院藥物化學(xué)系,博士(碩博連讀) 2007/09-2011/06,海南大學(xué),海洋學(xué)院制藥工程,學(xué)士 研究方向 1. 基于細(xì)胞凋亡中的關(guān)鍵調(diào)節(jié)子(如Bcl-2、Mcl-1等)的抗腫瘤藥物的設(shè)計(jì)、合成及活性研究 2. 小分子熒光探針的設(shè)計(jì)及生物成像 主持或參與的科研項(xiàng)目 [1] 國家自然科學(xué)基金青年項(xiàng)目:新型含氮雜環(huán)類Bcl-2/Mcl-1雙靶點(diǎn)抑制劑的設(shè)計(jì)、合成及生物活性研究(82003602),2021.01-2023.12. (主持) [2] 湖南省自然科學(xué)基金青年基金,新型吲唑類Bcl-2/Mcl-1雙重抑制劑的設(shè)計(jì)、合成及生物活性研究(2019JJ50145),2019.01-2021.12. (主持) [3] 湖南省教育廳科研項(xiàng)目一般項(xiàng)目,新型小分子Bcl-2/Mcl-1雙靶點(diǎn)抑制劑的設(shè)計(jì)、合成及生物活性研究(18C0325),2018.09-2020.12. (主持) [4] 湖南科技大學(xué)博士科研基金,新型吲哚類衍生物的設(shè)計(jì)、合成及抗腫瘤活性研究(E51765),2018.01-2019.12. (主持) [5] 理論有機(jī)化學(xué)與功能分子教育部重點(diǎn)實(shí)驗(yàn)室開放課題項(xiàng)目:新型1,3,4-噁二唑衍生物的設(shè)計(jì)、合成及抗腫瘤活性研究(E21746),2017.01-2018.12。(主持) [6] 國家自然科學(xué)基金面上項(xiàng)目,新型CYP51和SDH雙靶點(diǎn)酰胺類殺菌劑的設(shè)計(jì)合成及構(gòu)效關(guān)系研究(21877034),2019.01-2022.12。(主要參與人) [7] 國家自然科學(xué)青年基金,銅催化C-H鍵活化與自由基介導(dǎo)構(gòu)筑C-C鍵的反應(yīng)研究(21703061),2018.01-2020.12。(第一參與人) [8] 國家自然科學(xué)基金面上項(xiàng)目,設(shè)計(jì)、合成具有HDAC和Bcl-2雙重抑制作用的新型抗腫瘤藥物(81373281),2014.01-2017.12。(主要參與人) 發(fā)表的主要論文 [1] Yichao Wan*, Jiabing Long, Han Gao, Zilong Tang, 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents, Eur. J. Med. Chem., 2021, 210: 112953. [2] Han Gao, Yichao Wan*, Yuhuan Tan, Xi Luo, Lin Li, Synthesis and Antifungal Activity of New N-Aryl-2-(2-hydroxyphenylamino)ethylenediamine Derivatives, Russ. J. Gen. Chem., 2021, 91: 122-127. [3] Yichao Wan*, Yuanhua Li, Chunxing Yan, Jiajun Wen, Zilong Tang, Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors, Bioorg. Chem., 2020, 104: 104217. [4] Yichao Wan*, Chunxing Yan, Han Gao, Tingting Liu**, Small-molecule PROTACs: novel agents for cancer therapy, Future Med. Chem., 2020, 12: 915-938. [5] Tingting Liu*, Yichao Wan, Yuliang Xiao, Chengcai Xia, Guiyun Duan, Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy, J. Med. Chem., 2020, 63: 8977-9002. [6] Yichao Wan*, Wei Li, Zipeng Liao, Mi Yan, Xuwang Chen, Zilong Tang, Selective MMP-13 inhibitors: promising agents for the therapy of Osteoarthritis, Curr. Med. Chem., 2019, 26: 1-17. [7] Yichao Wan*, Yuanhua Li, Chunxing Yan, Mi Yan, Zilong Tang**, Indole: A privileged scaffold for the design of anti-cancer agents, Eur. J. Med. Chem., 2019, 183: 111691. [8] Yichao Wan*, Yuanhua Li, Zhipeng Liao, Zilong Tang, Yi Li, Yunhui Zhao, Bin Xiong, A new xanthene-based fluorescent probe with a red light emission for selectively detecting glutathione and imaging in living cells, Spectrochim. Acta A Mol. Biomol. Spectrosc., 2019, 223: 117265. [9] Yichao Wan*, Shengzhuo He, Wei Li and Zilong Tang, Indazole Derivatives: Promising Anti-tumor Agents, Anticancer Agents Med. Chem., 2018, 18: 1228-1234. [10] Yichao Wan, Ningning Dai, ZilongTang, Hao Fang*, Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents, Eur. J. Med. Chem., 2018, 146: 471-482. [11] Yichao Wan, Tingting Liu, Xiaoxian Li, Chen Chen, Hao Fang*, Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino side chains, Bioorg. Med. Chem., 2017, 25: 138-152. [12] Yichao Wan, Junhua Wang, Feng’e Sun, Minglu Chen, Xuben Hou, Hao Fang*, Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors, Bioorg. Med. Chem., 2015, 23: 7685-7693. [13] Yichao Wan, Shaolei Wu, Guizhi Xiao, Tingting Liu, Xuben Hou, Chen Chen, Peng Guan, Xinying Yang, Hao Fang*, Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors, Bioorg. Med. Chem., 2015, 23: 1994–2003. [14] Yichao Wan, Tingting Liu, Xuben Hou, Yanyan Dun, Peng Guan and Hao Fang*, Antagonists of IAP Proteins: Novel Anti-Tumor Agents, Curr. Med. Chem., 2014, 21: 3877-3892. [15] Tingting Liu, Yichao Wan, Renshuai Liu, Lin Ma, Minyong Li, Hao Fang* Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors, Bioorg. Med. Chem., 2017, 25: 1939-1948. |
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 07化學(xué)280分求調(diào)劑 +4 | 722865 2026-03-23 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 298-一志愿中國農(nóng)業(yè)大學(xué)-求調(diào)劑 +11 | 手機(jī)用戶 2026-03-17 | 12/600 |
|
|
[考研] 求調(diào)劑 +7 | 十三加油 2026-03-21 | 7/350 |
|
|
[考研] 336化工調(diào)劑 +4 | 王大坦1 2026-03-23 | 5/250 |
|
|
[論文投稿] 急發(fā)核心期刊論文 +3 | 賢達(dá)問津 2026-03-23 | 5/250 |
|
|
[考研]
|
孅華 2026-03-22 | 4/200 |
|
|
[考研] 311求調(diào)劑 +6 | 冬十三 2026-03-18 | 6/300 |
|
|
[考研] 260求調(diào)劑 +3 | 朱芷琳 2026-03-20 | 4/200 |
|
|
[考研] 286分人工智能專業(yè)請求調(diào)劑愿意跨考! +4 | lemonzzn 2026-03-17 | 8/400 |
|
|
[考研] 考研調(diào)劑 +3 | 呼呼?~+123456 2026-03-21 | 3/150 |
|
|
[考研] 材料工程專碩 348分求調(diào)劑 +3 | 冬辭. 2026-03-17 | 5/250 |
|
|
[考研] 0703化學(xué)297求調(diào)劑 +3 | Daisy☆ 2026-03-20 | 3/150 |
|
|
[考研] 22 350 本科985求調(diào)劑,求老登收留 +3 | 李軼男003 2026-03-20 | 3/150 |
|
|
[考研] 330求調(diào)劑0854 +3 | assdll 2026-03-21 | 3/150 |
|
|
[考研] 332求調(diào)劑 +3 | 鳳凰院丁真 2026-03-20 | 3/150 |
|
|
[考研] 求調(diào)劑 +6 | Mqqqqqq 2026-03-19 | 6/300 |
|
|
[考研] 332求調(diào)劑 +4 | ydfyh 2026-03-17 | 4/200 |
|
|
[考研]
|
然11 2026-03-19 | 4/200 |
|
|
[考博] 申博26年 +3 | 八6八68 2026-03-19 | 3/150 |
|
|
[考研] 0703化學(xué)調(diào)劑 +3 | 妮妮ninicgb 2026-03-17 | 3/150 |
|